Author Archives: George MacDonald

JMP Securities Believes Won’t Stop Here

JMP Securities analyst Aaron Hecht reiterated an Outperform rating on Omega Healthcare (NYSE: OHI) on February 18 and set a price target of $43.00. The company’s shares closed last Monday at $37.01, close to its 52-week high of $39.31. Omega

Nio (NIO) Receives a Buy from Deutsche Bank

Deutsche Bank analyst Edison Yu reiterated a Buy rating on Nio (NYSE: NIO) yesterday and set a price target of $60.00. The company’s shares closed last Tuesday at $41.93. Nio has an analyst consensus of Moderate Buy, with a price

Lake Street Reiterates Buy on Aquestive Therapeutics Shares, Sees 68% Upside For The Stock

In a research report sent to investors on Wednesday, Lake Street analyst Thomas Flaten reiterated a Buy rating on Aquestive Therapeutics (NASDAQ:AQST)with a price target of $7, which implies an upside of 68% from current levels. According to TipRanks.com, which

Deutsche Bank Reiterates Buy on Advantage Solutions Shares, Sees 19% Upside For The Stock

In a research report published on 3/8, Deutsche Bank analyst Ashish Sabadra reiterated a Buy rating on Advantage Solutions (NASDAQ:ADV)with a price target of $14, which implies an upside of 19% from current levels. According to TipRanks.com, which measures analysts’

J.P. Morgan Keeps Their Overweight Rating on BorgWarner (BWA)

In a report released today, Ryan Brinkman from J.P. Morgan reaffirmed an Overweight rating on BorgWarner (NYSE: BWA), with a price target of $58.00. The company’s shares closed last Wednesday at $43.69. The word on The Street in general, suggests

William Blair Believes Won’t Stop Here

William Blair analyst Arjun Bhatia reiterated an Outperform rating on Atlassian (NASDAQ: TEAM) on January 29. The company’s shares closed last Tuesday at $243.59, close to its 52-week high of $250.03. Currently, the analyst consensus on Atlassian is a Moderate